Become part of our readers´ community

12. November 2017

You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

First LEA assay launched

14. März 2018

LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses...

Read more

Awarded work starting into a prospective study: Hemoglobinopathies and Thalassemias

14. März 2018

Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now...

Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

7. März 2018

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...

Read more

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

21. November 2017

The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...

Read more

We were there: Asia-Pacific Conference on Human Genetics

6. November 2017

We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to...

Read more

Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

16. Oktober 2017

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...

Read more

ARCHIMEDlife @ MSACL Salzburg: Mass Spectrometry Applications to Clinical Lab, 10.- 14.9.17

13. September 2017

We are proud to be a regular part of MSACL –  this year in Salzburg from 10.- 14. September...

Read more

Our new Website is online!

1. September 2017

WELCOME! We are happy to announce that our new website is online. From now on you can find all...

Read more